Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients-Reference-Cited by-同舟云学术

Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients

Published:2018-10-31 Issue:12 Volume:32 Page:e13424
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Seibert Stephan R.¹,Schladt David P.²,Wu Baolin³,Guan Weihua³,Dorr Casey⁴,Remmel Rory P.⁵,Matas Arthur J.⁶,Mannon Roslyn B.⁷,Israni Ajay K.⁸^ORCID,Oetting William S.⁹,Jacobson Pamala A.¹^ORCID

Affiliation:

1. Department of Experimental and Clinical Pharmacology, College of Pharmacy; University of Minnesota; Minneapolis Minnesota

2. Chronic Disease Research Group, Minneapolis Medical Research Foundation; Hennepin County Medical Center; Minneapolis Minnesota

3. Division of Biostatistics, School of Public Health; University of Minnesota; Minneapolis Minnesota

4. Minneapolis Medical Research Foundation; Hennepin County Medical Center; Minneapolis Minnesota

5. Department of Medicinal Chemistry, College of Pharmacy; University of Minnesota; Minneapolis Minnesota

6. Department of Surgery; University of Minnesota; Minneapolis Minnesota

7. Department of Nephrology; University of Alabama; Birmingham Alabama

8. Division of Nephrology, Hennepin County Medical Center; Epidemiology & Community Health; University of Minnesota; Minneapolis Minnesota

9. Department of Genetics, Cell Biology, and Development; University of Minnesota; Minneapolis Minnesota

Funder

National Institute of Allergy and Infectious Diseases

University of Minnesota

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.13424/fullpdf

Reference42 articles.

1. Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics;Israni;Transpl Int,2013

2. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management;Shuker;Transplant Rev (Orlando),2015

3. Genomewide association study of tacrolimus concentrations in African American kidney transplant recipients identifies multiple CYP3A5 alleles;Oetting;Am J Transplant,2016

4. Multigene predictors of tacrolimus exposure in kidney transplant recipients;Pulk;Pharmacogenomics,2015

5. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients;Zhang;Int J Clin Pharmacol Ther,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic versus self-reported African ancestry of the recipient and neighborhood predictors of kidney transplantation outcomes in two multiethnic urban cohorts;American Journal of Transplantation;2024-02

2. HLA B eplet mismatches in the context of delayed graft function and low tacrolimus trough levels are risk factors influencing the generation of de novo donor-specific antibodies and acute rejection in the early stage after kidney transplantation;Transplant Immunology;2023-12

3. Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation;World Journal of Transplantation;2023-09-18

4. The importance of avoiding time-dependent bias when testing the prognostic value of an intervening event — Two acute cellular rejection examples in intestinal transplantation;American Journal of Transplantation;2023-06

5. Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?;Transplantation Direct;2023-03-29